GPT Healthcare Limited has announced an earnings call to discuss its financial performance for the third quarter and nine months ended December 31, 2025. The company made this announcement on January 27, 2026, in compliance with regulatory requirements under SEBI listing obligations.

Earnings Call Details

The conference call is scheduled to provide analysts and investors with comprehensive insights into the company's Q3 & 9MFY26 financial results. The call will focus on discussing the un-audited financial results for the specified period.

Company Participants

The earnings call will feature key members of GPT Healthcare's senior management team who will present the financial results and address questions from participants.

Conference Access Information

The company has provided multiple dial-in options to accommodate participants from different regions. Universal dial-in numbers include +91 22 6280 1550 and +91 22 7115 8378 for domestic participants.

International Access

International participants can join using toll-free numbers specific to their regions:

• Hong Kong: 800964448
• UK: 08081011573
• Singapore: 8001012045
• USA: 18667462133

Registration and Contact Details

The company has encouraged participants to pre-register through their Diamond Pass system to avoid wait times during the call. For investor relations queries, participants can contact Mr. Arihant Sonthalia and Ms. Mansi Mohta at ir@gptgroup.co.in .

MUFG Intime India Private Limited is coordinating the conference call arrangements, with Mr. Nikunj Seth and Ms. Sejal Bhattar serving as points of contact. The announcement was signed by Company Secretary and Compliance Officer Ankur Sharma, ensuring compliance with SEBI regulations for listed companies.

GPT Healthcare Limited has announced a strategic appointment to enhance its investor relations capabilities. The healthcare company has engaged MUFG Intime India Private Ltd as its investor relations agency, marking a significant step toward strengthening its capital market presence.

Appointment Details

The company has formally appointed MUFG Intime India Private Ltd to provide investor relations advisory services, with the engagement becoming effective from January 1, 2026. This appointment was announced through a regulatory filing under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Strategic Objectives

The appointment is designed to achieve multiple strategic objectives for GPT Healthcare Limited. The company aims to strengthen its investor communication framework, enhance transparency in its operations, and improve its overall visibility in the capital markets. These initiatives are expected to facilitate better engagement with existing and potential investors.

Communication Infrastructure

As part of this investor relations enhancement initiative, GPT Healthcare Limited has established dedicated communication channels for investor engagement. The company has designated ir@gptgroup.co.in as the specific email address for all investor-related queries, concerns, and requests. This centralized communication approach is intended to streamline investor interactions and ensure prompt responses to stakeholder inquiries.

Regulatory Compliance

The announcement demonstrates GPT Healthcare Limited's commitment to maintaining robust corporate governance standards and regulatory compliance. The appointment was made in accordance with Regulation 30 of the SEBI Listing Regulations, ensuring full transparency with stock exchanges and investors. The company has also made this information available on its website at www.ilshospitals.com , further emphasizing its commitment to transparent communication.

This strategic move reflects GPT Healthcare Limited's focus on enhancing its investor relations capabilities and maintaining strong relationships with the investment community through professional advisory services.